Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Wald, Ron ^a,b   Yan, Andrew T ^a,b   Perl, Jeffrey ^a,b   Jiang, Depeng ^c,d   Donnelly, M Sandra ^a,b   Leong Poi, Howard ^a,b   McFarlane, Philip A ^a,b   Weinstein, Jordan J ^a,b   Goldstein, Marc B ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

end stage renal disease; in centre nocturnal hemodialysis; left ventricular mass

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LONGITUDINAL STUDY; MALE; NOCTURNAL HEMODIALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; ECHOGRAPHY; HEART VENTRICLE; HOME DIALYSIS; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; TIME;

ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; FEMALE; HEART VENTRICLES; HEMODIALYSIS, HOME; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84855866369     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-322260388     Document Type: Article

References (43)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32(5 Suppl 3): S112-119. (Pubitemid 28527268)
2. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005, 353(3):238-248. (Pubitemid 41058323)
3. Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006, 70(7):1318-1324. (Pubitemid 44435184)
4. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009, 360(14):1395-1407.
5. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gronhagen-Riska C, Dasgupta T, et al: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377(9784):2181-2192.
6. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation 2007, 116(1):85-97. (Pubitemid 47016250)
7. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial. JAMA 2007, 298(11):1291-1299. (Pubitemid 47443343)
8. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287-2300.
9. Innes A, Charra B, Burden RP, Morgan AG, Laurent G: The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 1999, 14(4):919-922. (Pubitemid 29155147)
10. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb- Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, Kutner NG: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009, 76(9):984-990.
11. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U: Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001, 38(2):371-376.
12. Eloot S, Van Biesen W, Dhondt A, Van de Wynkele H, Glorieux G, Verdonck P, Vanholder R: Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2008, 73(6):765-770. (Pubitemid 351323256)
13. Yuen D, Pierratos A, Richardson RM, Chan CT: The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 2006, 21(5):1407-1412.
14. Bugeja A, Dacouris N, Thomas A, Marticorena R, McFarlane P, Donnelly S, Goldstein M: In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol 2009, 4(4):778-783.
15. Troidle L, Finkelstein F, Hotchkiss M, Leypoldt JK: Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis. Hemodial Int 2009, 13(4):487-491.
16. Cravedi P, Ruggenenti P, Mingardi G, Sghirlanzoni MC, Remuzzi G: Thriceweekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapy. Int J Artif Organs 2009, 32(1):12-19.
17. Powell JR, Oluwaseun O, Woo YM, Padmanabhan N, Narasinghan E, Latta C, Tortolano J, Jardine AG, Geddes CC: Ten Years Experience of In-Center Thrice Weekly Long Overnight Hemodialysis. Clin J Am Soc Nephrol 2009, 4(6):1097-1101.
18. David S, Kumpers P, Eisenbach GM, Haller H, Kielstein JT: Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 2009, 24(7):2232-2240.
19. Ok E, Duman S, Asci G, Tumuklu M, Onen Sertoz O, Kayikcioglu M, Toz H, Adam SM, Yilmaz M, Tonbul HZ, Ozkahya M: Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: A prospective, case-controlled study. Nephrol Dial Transplant.
20. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(4 Suppl 3):S1-201.
21. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004, 43(5 Suppl 1): S1-290.
22. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006, 17(3 Suppl 1):S1-27.
23. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006, 48(Suppl 1):S248-273.
24. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006, 47(5 Suppl 3):S11-145.
25. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007, 50(3):471-530.
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57(6):450-458. (Pubitemid 16119719)
27. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18(12):1440-1463. (Pubitemid 41821197)
28. Singer J: Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. Journal of Educational and Behavioral Statistics 1998, 24:323-355.
29. Verbeke G, Molenberghs G: Linear mixed models for longitudinal data. New York, NY: Springer Verlag; 2000.
30. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995, 47(1):186-192.
31. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994, 4(7):1486-1490.
32. Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG: Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005, 67(1):217-226. (Pubitemid 40019243)
33. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B: Prognostic significance of left ventricular mass change during treatment of hypertension. Jama 2004, 292(19):2350-2356. (Pubitemid 39491919)
34. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in endstage renal disease. J Am Soc Nephrol 2000, 11(5):912-916. (Pubitemid 30241725)
35. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001, 12(12):2759-2767. (Pubitemid 33115424)
36. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002, 61(6):2235-2239. (Pubitemid 34539341)
37. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, et al: The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011, 80(10):1080-1091.
38. Cafazzo JA, Leonard K, Easty AC, Rossos PG, Chan CT: Patient-Perceived Barriers to the Adoption of Nocturnal Home Hemodialysis. Clin J Am Soc Nephrol 2009, 4(4):784-789.
39. Foley RN, Curtis BM, Randell EW, Parfrey PS: Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 5(5):805-813.
40. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS: The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993, 65(2):212-214. (Pubitemid 23268027)
41. Constantine G, Shan K, Flamm SD, Sivananthan MU: Role of MRI in clinical cardiology. Lancet 2004, 363(9427):2162-2171. (Pubitemid 38844160)
42. Hunold P, Vogt FM, Heemann UW, Zimmermann U, Barkhausen J: Myocardial mass and volume measurement of hypertrophic left ventricles by MRI-study in dialysis patients examined before and after dialysis. J Cardiovasc Magn Reson 2003, 5(4):553-561. (Pubitemid 37420770)
43. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS: Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int 2007, 71(4):349-359. (Pubitemid 46227095)